<SEC-DOCUMENT>0001493152-18-005575-index.html : 20180420 <SEC-HEADER>0001493152-18-005575.hdr.sgml : 20180420 <ACCEPTANCE-DATETIME>20180420172955 ACCESSION NUMBER: 0001493152-18-005575 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20180420 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180420 DATE AS OF CHANGE: 20180420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-27072 FILM NUMBER: 18767605 BUSINESS ADDRESS: STREET 1: 860 N. ORANGE AVENUE STREET 2: SUITE B CITY: ORLANDO STATE: FL ZIP: 32801 BUSINESS PHONE: 407-271-8516 MAIL ADDRESS: STREET 1: 860 N. ORANGE AVENUE STREET 2: SUITE B CITY: ORLANDO STATE: FL ZIP: 32801 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8-k.htm <TEXT> Document 1 - file: form8-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>ex4-1.htm <TEXT> Document 2 - file: ex4-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>3 <FILENAME>ex4-2.htm <TEXT> Document 3 - file: ex4-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>4 <FILENAME>ex5-1.htm <TEXT> Document 4 - file: ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>5 <FILENAME>ex10-1.htm <TEXT> Document 5 - file: ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>6 <FILENAME>ex99-1.htm <TEXT> Document 6 - file: ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>image_001.jpg <TEXT> Document 7 - file: image_001.jpg
</DOCUMENT> </SEC-DOCUMENT>